Leveraging biomimicry & evidence-based medicine
Our Story
The company was born in 2017 as a spin-off from BRAIN Biotech AG, a leading German biotech company that focuses on harnessing biological diversity to develop innovative solutions.
Dan Wright
Chairman
Dan was a founding partner and COO of NorthEdge Capital, a U.K. mid-market buyout firm focused on investments in the North of England. He serves as SolasCure’s independent Board member, focused on governance issues.
Dr. Sam Bakri
Founder & CEO
Sam is a serial healthcare entrepreneur. He was the CEO and co-founder of Kind Consumer, a UK-based medical technology company, the co-founder of AIDA Health (backed by Mayo Clinic) and Gelmetix Healthcare, where he is Vice Chairman.
Adriaan Moelker
Director
Adriaan is the CEO of BRAIN Biotech AG. Before joining BRAIN Biotech AG, he held a wide variety of management positions during his 30-year career, and his particular focus has been on Biotechnology.
Riad Armanious
Director
Riad is the CEO of Eva Pharma, one of the leading specialty pharma companies in Africa. Riad is active in the YPO (Young Presidents Association), the “T20” foundation and Vice Chairman in the Egyptian Industrial Chamber of Pharmaceuticals.
François Fournier
Director
François is CEO & President of Virbac. He is the former head of Wound Care and former head of Asia-Pac at Smith & Nephew. François has been in the industry for about 20 years with worldwide experience in the pharmaceutical industry in a multi-business environment, creating and growing markets in North America, Europe, Middle East Africa, Asia, and Latin America.
Â
Frank Goebel
Director
Frank is the former CFO of BRAIN Biotech AG. He previously spent 15 years in Structured Finance at a global investment bank. Formerly a controller in a German industrial company.
Jane Hart
Director
Mission & Values
Our mission is to support healthcare professionals with wound care products that significantly improve the health and wellbeing of patients with chronic wounds
